Jun 20 |
Eli Lilly Has a New Drug That Could Push the Stock Higher
|
Jun 20 |
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs
|
Jun 20 |
Eli Lilly Files More Lawsuits at Sellers of Counterfeit Mounjaro, Zepbound
|
Jun 20 |
Eli Lilly ramps up efforts against fake weight loss drugs
|
Jun 20 |
Here's Why Eli Lilly (LLY) is Probably the Best Drug Stock Now
|
Jun 20 |
Eli Lilly's Growth Prospects Just Got a Huge Upgrade
|
Jun 20 |
Eli Lilly Expands Fight Against Counterfeit Obesity Drug Zepbound With New Legal Actions
|
Jun 20 |
Why Wall Street Is Chasing Ozempic Wannabes
|
Jun 20 |
The Fed Needs to Cut Rates Eventually Amid This Economic Slowdown. Here’s Why, and 4 Other Things to Know Today.
|
Jun 19 |
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
|